BIOTON S.A. (WSE:BIO)

Poland flag Poland · Delayed Price · Currency is PLN
4.160
-0.130 (-3.03%)
Mar 3, 2026, 2:52 PM CET
Market Cap368.36M +15.3%
Revenue (ttm)295.81M +66.6%
Net Income-2.82M
EPS-0.03
Shares Out85.86M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume60,233
Average Volume35,957
Open4.230
Previous Close4.290
Day's Range4.060 - 4.240
52-Week Range3.370 - 4.700
Beta0.21
RSI55.74
Earnings DateFeb 27, 2026

About BIOTON

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1989
Employees 364
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BIO
Full Company Profile

Financial Performance

Financial Statements